Disclaimer: The information on this page is intended for Healthcare Professionals only.
A Conditional Marketing Authorisation (CMA) has been granted in the EU for the product Vaxzevria for active immunisation of individuals aged 18 years and older for the prevention of coronavirus disease 2019 (COVID-19). During the pandemic, Vaxzevria may also be distributed in packaging with the name COVID‑19 Vaccine AstraZeneca.